Increasing use of CAR‐T therapy occurs in conjunction with decreasing stem cell transplants with stable resource usage over a 6‐year period: Resource utilization implications

Documenti analoghi

• A 3‐step method for preparing cryopreserved samples of apheresis products for post‐thaw analysis yields a higher percentage of viable cells
  di: Dustin J. Strasburg, et al.
  Pubblicazione: (2024)
• A three‐step method for preparing cryopreserved samples of apheresis products for post‐thaw analysis yields a high recovery of viable cells
  di: Rosalie M. Sterner, et al.
  Pubblicazione: (2024)
• Successful re‐infusion of hepatitis E contaminated stem cells during autologous stem cell transplantation with ribavirin prophylaxis
  di: Hannah Sadler, et al.
  Pubblicazione: (2026)
• Comparison of biosimilar filgrastim and originator filgrastim for peripheral blood stem cell mobilization for allogeneic hematopoietic stem cell transplantation
  di: Moazzam Shahzad, et al.
  Pubblicazione: (2024)
• Feasibility and utility of a rapid ABO genotyping platform in transplantation and transfusion medicine
  di: Jun Liu, et al.
  Pubblicazione: (2025)